Filing Details
- Accession Number:
- 0001453687-21-000158
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-03 16:28:40
- Reporting Period:
- 2021-12-01
- Accepted Time:
- 2021-12-03 16:28:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1453687 | Selecta Biosciences Inc | SELB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1760229 | Carsten Brunn | C/O Selecta Biosciences, Inc. 65 Grove Street Watertown MA 02472 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-01 | 10,938 | $0.00 | 289,697 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-12-02 | 4,746 | $2.96 | 284,951 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2021-12-01 | 10,938 | $0.00 | 10,938 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
43,750 | No | 4 | M | Direct |
Footnotes
- Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
- The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.94 to $2.99. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Each restricted stock unit represents a contingent right to receive one share of common stock.
- This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date.